The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesWB: Use at a concentration of 1-5 µg/ml.
This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
FunctionMay be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
PathwayProtein modification; protein ubiquitination.
Ankyrin repeat and SOCS box containing 13 antibody
Ankyrin repeat and SOCS box containing protein 13 antibody
Ankyrin repeat and SOCS box protein 13 antibody
Ankyrin repeat domain containing SOCS box protein Asb 13 antibody
Ankyrin repeat domain containing SOCS box protein Asb13 antibody
ASB 13 antibody
Anti-ASB13 antibody images
Western blot - ASB13 antibody (ab57777)
Western blot against tagged recombinant protein immunogen using ab57777 ASB13 antibody at 1ug/ml. Predicted band size of immunogen is 37 kDa
References for Anti-ASB13 antibody (ab57777)
This product has been referenced in:
Zhang Y et al. miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer. Cancer Res71:3552-62 (2011).
Read more (PubMed: 21444677) »